Jump to ContentJump to Main Navigation

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Editorial Board Member: Gillery, Philippe / Kazmierczak, Steven / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Schlattmann, Peter / Whitfield, John B.

12 Issues per year


IMPACT FACTOR 2013: 2.955
Rank 5 out of 29 in category Medical Laboratory Technology in the 2013 Thomson Reuters Journal Citation Report/Science Edition

SCImago Journal Rank (SJR): 0.860
Source Normalized Impact per Paper (SNIP): 1.046

VolumeIssuePage

Issues

Reference materials (RMs) for analysis of the human factor II (prothrombin) gene G20210A mutation

Christoph L. Klein1 / János Márki-Zay2 / Philippe Corbisier3 / David Gancberg4 / Susan Cooper5 / Donato Gemmati6 / Walter-Michael Halbmayer7 / Steve Kitchen8 / Béla Melegh9 / Michael Neumaier10 / Johannes Oldenburg11 / Elisabeth Oppliger Leibundgut12 / Pieter H. Reitsma13 / Sandra Rieger14 / Heinz G. Schimmel15 / Michael Spannagl16 / Attilia Tordai17 / Alberto Tosetto18 / Sophie Visvikis19 / Renata Zadro20 / Christine Mannhalter21

1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

17.

18.

19.

20.

21.

Corresponding author: Christoph L. Klein, European Commission, Joint Research Centre, Institute for Reference Materials and Measurements, Retieseweg 111, 2440 Geel, Belgium Phone: +32-14-571634, Fax: +32-14-571548,

Citation Information: Clinical Chemical Laboratory Medicine. Volume 43, Issue 8, Pages 862–868, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: 10.1515/CCLM.2005.145, August 2005

Publication History

Received:
March 7, 2005
Accepted:
June 17, 2005

Abstract

The Scientific Committee of Molecular Biology Techniques (C-MBT) in Clinical Chemistry of the IFCC has initiated a joint project in co-operation with the European Commission, Joint Research Centre, Institute of Reference Materials and Measurements to develop and produce plasmid-type reference materials (RMs) for the analysis of the human prothrombin gene G20210A mutation. Although DNA tests have a high impact on clinical decision-making and the number of tests performed in diagnostic laboratories is high, issues of quality and quality assurance exist, and currently only a few RMs for clinical genetic testing are available. A gene fragment chosen was produced that spans all primer annealing sites published to date. Both the wild-type and mutant alleles of this gene fragment were cloned into a pUC18 plasmid and two plasmid RMs were produced. In addition, a mixture of both plasmids was produced to mimic the heterozygous genotype. The present study describes the performance of these reference materials in a commutability study, in which they were tested by nine different methods in 13 expert laboratories. This series of plasmid RMs are, to the best of our knowledge, the first plasmid-type clinical genetic RMs introduced worldwide.

Keywords: metrological traceability; molecular diagnostic testing; mutation; polymerase chain reaction; prothrombin; recombinant DNA; reference standards

Comments (0)

Please log in or register to comment.
Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.